Skip to main content
. 2020 Apr 30;26(2):259–266. doi: 10.5056/jnm19186

Table 3.

The Mean Difference in the Quality of Life Scale (Short Form Nepean Dyspepsia Index) Between Groups

Parameter Clidinium/chlordiazepoxide (n = 37) Placebo (n = 36) P-value


Baseline (mean ± SD) Week 4 (mean ± SD) Mean difference (95% CI) Baseline (mean ± SD) Week 4 (mean ± SD) Mean difference (95% CI)
Overall 30.38 ± 6.15 16.03 ± 4.86 –14.35 (–16.48, –12.23) 27.75 ± 7.24 24.31 ± 8.59 –3.44 (–5.77, –1.11) < 0.001
Tension 7.38 ± 1.69 3.76 ± 1.16 –3.62 (–4.30, –2.94) 6.58 ± 1.30 5.50 ± 1.80 –1.08 (–1.71, –0.46) < 0.001
Interference with daily activities 4.89 ± 2.71 2.73 ± 1.37 –2.16 (–2.99, –1.34) 4.44 ± 2.80 4.14 ± 2.44 –0.31 (–0.92, 0.30) 0.001
Eating/drinking 4.76 ± 1.86 3.14 ± 1.18 –1.62 (–2.23, –1.02) 5.08 ± 2.10 4.83 ± 1.96 –0.25 (–0.91, 0.41) 0.003
Knowledge/control 7.89 ± 1.54 3.62 ± 1.25 –4.27 (–4.92, –3.62) 7.31 ± 1.85 5.64 ± 2.03 –1.67 (–2.38, –0.95) < 0.001
Work/study 5.46 ± 2.86 2.78 ± 1.27 –2.68 (–3.58, –1.77) 4.33 ± 2.61 4.19 ± 2.55 –0.14 (–0.76, 0.48) < 0.001